BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7852530)

  • 1. Mutations in the RET protooncogene in sporadic pheochromocytomas.
    Lindor NM; Honchel R; Khosla S; Thibodeau SN
    J Clin Endocrinol Metab; 1995 Feb; 80(2):627-9. PubMed ID: 7852530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
    Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A.
    Quadro L; Panariello L; Salvatore D; Carlomagno F; Del Prete M; Nunziata V; Colantuoni V; Di Giovanni G; Brandi ML; Mannelli M
    J Clin Endocrinol Metab; 1994 Aug; 79(2):590-4. PubMed ID: 7913936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RET proto-oncogene in sporadic pheochromocytomas.
    Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
    Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas.
    Yoshimoto K; Kimura T; Tanaka C; Moritani M; Iwahana H; Itakura M
    Endocr J; 1996 Feb; 43(1):109-14. PubMed ID: 8732460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
    Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)].
    Komminoth P; Muletta-Feurer S; Soltermann A; Gemsenjäger E; Bürgi H; Staub JJ; Schönle E; Fried M; Vetter W; Spinas GA; Heitz PU
    Schweiz Med Wochenschr; 1996 Aug; 126(31-32):1329-38. PubMed ID: 8765374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
    Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
    Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas.
    Rodien P; Jeunemaitre X; Dumont C; Beldjord C; Plouin PF
    Horm Res; 1997; 47(4-6):263-8. PubMed ID: 9167962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
    Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
    J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.
    Komminoth P; Kunz E; Hiort O; Schröder S; Matias-Guiu X; Christiansen G; Roth J; Heitz PU
    Am J Pathol; 1994 Oct; 145(4):922-9. PubMed ID: 7943181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
    Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Huang SC; Koch CA; Vortmeyer AO; Pack SD; Lichtenauer UD; Mannan P; Lubensky IA; Chrousos GP; Gagel RF; Pacak K; Zhuang Z
    Cancer Res; 2000 Nov; 60(22):6223-6. PubMed ID: 11103773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type.
    Yoshimoto K; Tanaka C; Hamaguchi S; Kimura T; Iwahana H; Miyauchi A; Itakura M
    Endocr J; 1995 Apr; 42(2):265-70. PubMed ID: 7627271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic multiple endocrine neoplasia type 2A.
    Yamashita S
    Intern Med; 1999 Feb; 38(2):80. PubMed ID: 10225659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.